MedWatch

Danish biotech merger to attract major investors

Biotech companies Oncology Venture and Medical Prognosis Institute are planning a merger that will take the companies from the Swedish stock exchanges for growth companies to Stockholm's main market. "Investors and potential partners have expressed their desire for a one-stop-shop and this is what we comply with," says the CEO in both companies.

Photo: /ritzau/Sofie Mathiassen

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Related articles